Delayed Administration and Contraindicated Drugs Place Hospitalized Parkinson's Disease Patients at Risk; Doxorubicin Liposomal Mix-up; Avoid Mix-ups between Hydroxyprogesterone and Medroxyprogesterone
- 1 July 2015
- journal article
- research article
- Published by SAGE Publications in Hospital Pharmacy
- Vol. 50 (7), 559-563
- https://doi.org/10.1310/hpj5007-559
Abstract
These medication errors have occurred in health care facilities at least once. They will happen again—perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site ( www.ismp.org ), by calling 800-FAIL-SAFE, or via e-mail at ismpinfo@ismp.org . ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications.Keywords
This publication has 4 references indexed in Scilit:
- Assessment of appropriate medication administration for hospitalized patients with Parkinson’s diseaseParkinsonism & Related Disorders, 2012
- Medication management in people with Parkinson’s disease during surgical admissionsPostgraduate Medical Journal, 2010
- The Parkinsonism-Hyperpyrexia SyndromeNeurocritical Care, 2008
- Prescribing medications in Parkinson's disease (PD) patients during acute admissions to a District General HospitalParkinsonism & Related Disorders, 2007